Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis

• Main Authors: Tan, J, Liu, S, Segal, J.B, Alexander, G.C, McAdams-Demarco, M
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Review
• Published: 2020
• Subjects: acetylsalicylic acid; apixaban; dabigatran; placebo; rivaroxaban; warfarin; anticoagulant agent; atrial fibrillation; bleeding; brain ischemia; cerebrovascular accident; cohort analysis; disease association; drug use; end stage renal disease; evidence based medicine; gastrointestinal hemorrhage; human; meta analysis; mortality; observational study; quantitative analysis; randomized controlled trial (topic); Review; risk assessment; risk benefit analysis; systematic review; thrombosis; treatment response; complication; hemodialysis; Hemorrhage; Kidney Failure, Chronic; Stroke; Anticoagulants; Atrial Fibrillation; Humans; Renal Dialysis; Warfarin
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181332
• Institution: National University of Singapore

10.1186/s12882-016-0368-6